DELIARGYRIS EFTHYMIOS (Chief Medical Officer) received a stock award from CYTOSORBENTS CORP
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/4/2024ACC: 0001104659-24-043795
Officer· Chief Medical Officer
Since May 2020
+147K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
147K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+61K
Price / share
—
Trade value
—
% of position
17.5%
4/2/2024
348.43K→409.43K
Total
Net shares
+61K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/2/2024 | A · Award | +61K | — | — | 17.5% | 348.43K | 409.43K |
| Total | +61K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
86K shares
Shares
+86K
Strike price
0.955
Held after
86K
Exercisable
—
4/2/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock86K shares | 4/2/2024 | A · Award | +86K | 0.955 | — | 86K |